Chapter title |
Social cognition.
|
---|---|
Chapter number | 10 |
Book title |
Cognitive Enhancement
|
Published in |
Handbook of experimental pharmacology, January 2015
|
DOI | 10.1007/978-3-319-16522-6_10 |
Pubmed ID | |
Book ISBNs |
978-3-31-916521-9, 978-3-31-916522-6
|
Authors |
Patin, Alexandra, Hurlemann, René, Alexandra Patin, René Hurlemann |
Abstract |
Social cognition is a major problem underlying deficiencies in interpersonal relationships in several psychiatric populations. And yet there is currently no gold standard for pharmacological treatment of psychiatric illness that directly targets these social cognitive areas. This chapter serves to illustrate some of the most innovative attempts at pharmacological modulation of social cognition in psychiatric illnesses including schizophrenia, borderline personality disorder, autism spectrum disorders, antisocial personality disorder and psychopathy, social anxiety disorder, and posttraumatic stress disorder. Pharmacological modulation includes studies administering oxytocin, ecstasy (MDMA), modafinil, methylphenidate, and D-cycloserine. Furthermore, some background on social cognition research in healthy individuals, which could be helpful in developing future treatments, is provided as well as the potential for each drug as a long-term treatment option. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Unknown | 91 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 16 | 17% |
Student > Bachelor | 12 | 13% |
Student > Postgraduate | 7 | 8% |
Researcher | 7 | 8% |
Student > Master | 6 | 7% |
Other | 14 | 15% |
Unknown | 30 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 26 | 28% |
Medicine and Dentistry | 10 | 11% |
Neuroscience | 8 | 9% |
Agricultural and Biological Sciences | 3 | 3% |
Biochemistry, Genetics and Molecular Biology | 2 | 2% |
Other | 10 | 11% |
Unknown | 33 | 36% |